Neuroleptic drug treatment alters in vitro central neurotensin metabolism

Thomas P Davis, Alison Culling-Berglund

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Neurotensin (NT) has been shown to possess pharmacological properties associated with neuroleptic drugs. To determine if chronic haloperidol (HL; 3.5 mg/kg/day) or chlorpromazine (CPZ; 4.2 mg/kg/day) treatment affects central NT metabolism, HL and CPZ were perfused via Alzet® minipumps into male Sprague-Dawley rats for 8 days. Purified synaptosomal plasma membranes (pSPM) were isolated and time-course incubated with NT (100 μM; 30-120 min). All samples were analyzed by high resolution, reversed-phase high performance liquid chromatography. HL and CPZ caused an increase in NT metabolism at the pSPM. Although an increase in NT metabolism would result in a loss of biological activity, it does lead to a significant accumulation of the biologically active NT fragment NT-(9-13), which has been shown to bind to the NT receptor. Therefore, neuroleptic drug treatment alters NT metabolism at the pSPM, leading to the formation of a fragment with antinociceptive activity.

Original languageEnglish (US)
Pages (from-to)253-260
Number of pages8
JournalPsychoneuroendocrinology
Volume12
Issue number4
DOIs
StatePublished - 1987

Fingerprint

Neurotensin
Antipsychotic Agents
Cell Membrane
Neurotensin Receptors
Chlorpromazine
Haloperidol
Reverse-Phase Chromatography
In Vitro Techniques
Sprague Dawley Rats
High Pressure Liquid Chromatography
Pharmacology

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Psychology(all)

Cite this

Neuroleptic drug treatment alters in vitro central neurotensin metabolism. / Davis, Thomas P; Culling-Berglund, Alison.

In: Psychoneuroendocrinology, Vol. 12, No. 4, 1987, p. 253-260.

Research output: Contribution to journalArticle

@article{831b3fc6728540e8b8864d0ca46443c7,
title = "Neuroleptic drug treatment alters in vitro central neurotensin metabolism",
abstract = "Neurotensin (NT) has been shown to possess pharmacological properties associated with neuroleptic drugs. To determine if chronic haloperidol (HL; 3.5 mg/kg/day) or chlorpromazine (CPZ; 4.2 mg/kg/day) treatment affects central NT metabolism, HL and CPZ were perfused via Alzet{\circledR} minipumps into male Sprague-Dawley rats for 8 days. Purified synaptosomal plasma membranes (pSPM) were isolated and time-course incubated with NT (100 μM; 30-120 min). All samples were analyzed by high resolution, reversed-phase high performance liquid chromatography. HL and CPZ caused an increase in NT metabolism at the pSPM. Although an increase in NT metabolism would result in a loss of biological activity, it does lead to a significant accumulation of the biologically active NT fragment NT-(9-13), which has been shown to bind to the NT receptor. Therefore, neuroleptic drug treatment alters NT metabolism at the pSPM, leading to the formation of a fragment with antinociceptive activity.",
author = "Davis, {Thomas P} and Alison Culling-Berglund",
year = "1987",
doi = "10.1016/0306-4530(87)90049-7",
language = "English (US)",
volume = "12",
pages = "253--260",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Neuroleptic drug treatment alters in vitro central neurotensin metabolism

AU - Davis, Thomas P

AU - Culling-Berglund, Alison

PY - 1987

Y1 - 1987

N2 - Neurotensin (NT) has been shown to possess pharmacological properties associated with neuroleptic drugs. To determine if chronic haloperidol (HL; 3.5 mg/kg/day) or chlorpromazine (CPZ; 4.2 mg/kg/day) treatment affects central NT metabolism, HL and CPZ were perfused via Alzet® minipumps into male Sprague-Dawley rats for 8 days. Purified synaptosomal plasma membranes (pSPM) were isolated and time-course incubated with NT (100 μM; 30-120 min). All samples were analyzed by high resolution, reversed-phase high performance liquid chromatography. HL and CPZ caused an increase in NT metabolism at the pSPM. Although an increase in NT metabolism would result in a loss of biological activity, it does lead to a significant accumulation of the biologically active NT fragment NT-(9-13), which has been shown to bind to the NT receptor. Therefore, neuroleptic drug treatment alters NT metabolism at the pSPM, leading to the formation of a fragment with antinociceptive activity.

AB - Neurotensin (NT) has been shown to possess pharmacological properties associated with neuroleptic drugs. To determine if chronic haloperidol (HL; 3.5 mg/kg/day) or chlorpromazine (CPZ; 4.2 mg/kg/day) treatment affects central NT metabolism, HL and CPZ were perfused via Alzet® minipumps into male Sprague-Dawley rats for 8 days. Purified synaptosomal plasma membranes (pSPM) were isolated and time-course incubated with NT (100 μM; 30-120 min). All samples were analyzed by high resolution, reversed-phase high performance liquid chromatography. HL and CPZ caused an increase in NT metabolism at the pSPM. Although an increase in NT metabolism would result in a loss of biological activity, it does lead to a significant accumulation of the biologically active NT fragment NT-(9-13), which has been shown to bind to the NT receptor. Therefore, neuroleptic drug treatment alters NT metabolism at the pSPM, leading to the formation of a fragment with antinociceptive activity.

UR - http://www.scopus.com/inward/record.url?scp=0023224809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023224809&partnerID=8YFLogxK

U2 - 10.1016/0306-4530(87)90049-7

DO - 10.1016/0306-4530(87)90049-7

M3 - Article

VL - 12

SP - 253

EP - 260

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 4

ER -